Boston Sci Buys Asthma Treatment Maker For $443M
Medical device maker Boston Scientific Corp. said Monday that it would pay up to $443.5 million to acquire privately held Asthmatx Inc., which produces and markets a recently approved nondrug treatment...To view the full article, register now.
Already a subscriber? Click here to view full article